Antibody specific to spike protein of SARS-CoV-2 and uses thereof
US11866485B2 · kind B2 · utility
6Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2022 |
| Grant date | Jan 9, 2024 |
| Priority date | — |
| Expiry date | Oct 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-CoV-2. The present disclosure also relates to a pharmaceutical composition, a method for treating and/or preventing diseases and/or disorders caused by a coronavirus in a subject in need thereof, and a method for detecting a coronavirus in a sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.